Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why does diabetes increase atherosclerosis? I don't know!

Ira J Goldberg1

  • 1Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA. ijg3@columbia.edu

The Journal of Clinical Investigation
|September 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac Lipid Metabolism: Cells, Metabolites, and Rhythms.

Circulation research·2026
Same author

The N-terminus of apolipoprotein B mediates the interaction of atherogenic lipoproteins with endothelial cells.

The Journal of clinical investigation·2026
Same author

Alveolar type 2 cell LRP1 is needed for surfactant phospholipid metabolism and pulmonary function in mice.

Journal of lipid research·2026
Same author

Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trial.

Nature medicine·2026
Same author

A Road Map to Understanding Cardiovascular Disease in Diabetes: From the AHA Strategically Focused Research Network in Cardiometabolic Health and Type 2 Diabetes.

Circulation research·2026
Same author

Non-remnant triglyceride-rich lipoproteins due to lipoprotein lipase deficiency increase atherosclerosis in mice.

Nature communications·2026
Same journal

ATR senses stiff extracellular matrix to promote epithelial-to-mesenchymal transition and immune suppression.

The Journal of clinical investigation·2026
Same journal

A peripheral subpopulation of retinal pigment epithelium resists oxidative damage through SERPINE3-mediated Caspase-1 inhibition.

The Journal of clinical investigation·2026
Same journal

PTEN deficiency confers sensitivity to ATR inhibitor-based treatment in high-grade serous ovarian cancer.

The Journal of clinical investigation·2026
Same journal

CD20+ T follicular helper-like cells drive antigen-specific autoimmunity in bullous pemphigoid.

The Journal of clinical investigation·2026
Same journal

Fate-mapping infiltrating monocytes following experimental myocardial infarction revealsdifferentiation trajectories in the infarcted heart.

The Journal of clinical investigation·2026
Same journal

Pharmacokinetics and pharmacodynamics of a long-acting monoclonal antibody against malaria in African adults.

The Journal of clinical investigation·2026
See all related articles

This study introduces a new mouse model for diabetes and atherosclerosis, showing accelerated vascular lesions in diabetic mice. Insulin therapy effectively reduced these lesions, offering a better way to study diabetes-related vascular disease.

Area of Science:

  • Cardiovascular Research
  • Metabolic Disorders
  • Vascular Biology

Background:

  • Diabetes mellitus is strongly linked to atherosclerosis and its complications.
  • Previous small-animal models have struggled to accurately replicate diabetes-accelerated vascular disease, often confounded by hyperlipidemia.
  • Differentiating the impact of hyperglycemia versus lipid abnormalities on vascular lesions has been challenging.

Discussion:

  • The new mouse model demonstrates accelerated atherosclerosis initiation in diabetic conditions.
  • Insulin therapy was shown to effectively reduce the development of atherosclerosis in these diabetic mice.
  • The model exhibits increased intra-arterial hemorrhage, potentially indicating less stable atherosclerotic plaques.

Key Insights:

  • A novel mouse model successfully links diabetes to accelerated atherosclerosis without confounding hyperlipidemia.

Related Experiment Videos

  • This model allows for clearer investigation into hyperglycemia's direct effects on vascular lesion development.
  • Insulin therapy demonstrates a protective effect against accelerated atherosclerosis in this diabetic model.

    • Outlook:

    • This model provides a valuable tool for dissecting the mechanisms of diabetes-accelerated atherosclerosis.
    • Further research can explore plaque stability and hemorrhage in diabetic vascular disease.
    • The findings may inform therapeutic strategies for managing cardiovascular complications in diabetes mellitus.